Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
COYA
#3330
Coya Therapeutics, Inc. Common Stock
4.9
6
+1.22%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+1.22%
Monthly Change
+2.06%
6 month change
-25.30%
Year Change
-24.04%
Previous Close
4.9
0
Open
4.9
6
Bid
Ask
Low
4.9
6
High
4.9
6
Volume
2
Markets
US Stock Market
Healthcare
COYA
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
16.71 M
16.72 M
16.72 M
16.73 M
20.92 M
—
Valuation ratios
Enterprise value
76.66 M
57.53 M
72.71 M
66.37 M
91.17 M
287.78 M
Price to earnings ratio
-9.77
-5.85
-6.05
-4.64
-5.14
-21.67
Price to sales ratio
7.75
24.57
26.01
226.96
23.91
301.44
Price to cash flow ratio
-8.6
-8.49
-6.44
-5.53
-7.7
-28.15
Price to book ratio
0.68
2.21
0.71
0.68
0.72
4.31
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.11
-0.07
-0.19
-0.18
-0.07
-0.5
Return on equity %
-0.13
-0.07
-0.22
-0.22
-0.08
-0.59
Return on invested capital %
—
—
-1 557.19
-3 149.88
-998.9
—
Gross margin %
—
100
100
100
100
400
Operating margin %
—
-209.03 K
-2 976.89
-3 920.47
-68.26
-216 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
-149.37 K
-2 833.35
-3 725.17
-59.36
-155.99 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
15.31
11.59
8.84
7.43
8.73
36.58
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0.01
0
0.11
0.12
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.36
-0.16
-0.17
-0.35
-0.07
-0.74
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.04
2.51
2.12
1.78
1.68
8.1
Net current asset value per share
2.33
2.91
2.29
2
1.91
9.12
Tangible book value per share
2.1
2.6
2
1.69
1.63
7.92
Working capital per share
2.18
2.66
2.04
1.73
1.69
8.12
Book value per share
2.1
2.6
2
1.69
1.63
7.92
News
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target
Coya Therapeutics secures $11.1 million in private placement
Coya Therapeutics advances ALS and FTD clinical trials in 2026
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock at $18
Tracking David Einhorn’s Greenlight Capital Portfolio – Q3 2025 Update (NYSE:GRBK)
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock
H.C. Wainwright reaffirms Buy rating on Coya Therapeutics stock at $18 target
Coya Therapeutics closes $23 million public offering of common stock
Coya Therapeutics stock falls after pricing $20 million public offering
Coya Therapeutics prices $20 million public offering of common stock
Coya Therapeutics announces common stock offering to fund operations
Why David Einhorn’s Greenlight prefers this tiny biotech over AI ‘excitement’